Oelke M - Search Results

1

Long-term safety, tolerability and efficacy of flexible-dose fesoterodine in elderly patients with overactive bladder: open-label extension of the SOFIA trial.

Wagg A, Khullar V, Michel MC, Oelke M, Darekar A, Bitoun CE. Wagg A, et al. Among authors: oelke m. Neurourol Urodyn. 2014 Jan;33(1):106-14. doi: 10.1002/nau.22383. Epub 2013 Mar 4. Neurourol Urodyn. 2014. PMID: 23460503 Clinical Trial.

2

[Medical therapy of urinary incontinence].

Oelke M, de la Rosette JJ, Michel MC, Jonas U. Oelke M, et al. Internist (Berl). 2005 Jan;46(1):75-82. doi: 10.1007/s00108-004-1334-0. Internist (Berl). 2005. PMID: 15609033 Review. German.

3

Safety and tolerability of duloxetine in women with stress urinary incontinence.

Oelke M, Roovers JP, Michel MC. Oelke M, et al. BJOG. 2006 May;113 Suppl 1:22-6. doi: 10.1111/j.1471-0528.2006.00880.x. BJOG. 2006. PMID: 16529566 Review.

4

[Anticholinergics for overactive bladder: does subtype selectivity play a role?].

Michel MC, Barendrecht MM, Oelke M. Michel MC, et al. Among authors: oelke m. Urologe A. 2006 Jul;45(7):826-9. doi: 10.1007/s00120-006-1075-x. Urologe A. 2006. PMID: 16767455 Review. German.

5

Relationships among symptoms, bother, and treatment satisfaction in overactive bladder patients.

Michel MC, Oelke M, Goepel M, Beck E, Burkart M. Michel MC, et al. Among authors: oelke m. Neurourol Urodyn. 2007;26(2):190-5. doi: 10.1002/nau.20367. Neurourol Urodyn. 2007. PMID: 17096320 Clinical Trial.

6

Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based?

Barendrecht MM, Oelke M, Laguna MP, Michel MC. Barendrecht MM, et al. Among authors: oelke m. BJU Int. 2007 Apr;99(4):749-52. doi: 10.1111/j.1464-410X.2006.06742.x. Epub 2007 Mar 16. BJU Int. 2007. PMID: 17233798 Review.

7

Pharmacologic treatment of male stress urinary incontinence: systematic review of the literature and levels of evidence.

Tsakiris P, de la Rosette JJ, Michel MC, Oelke M. Tsakiris P, et al. Among authors: oelke m. Eur Urol. 2008 Jan;53(1):53-9. doi: 10.1016/j.eururo.2007.09.037. Epub 2007 Oct 1. Eur Urol. 2008. PMID: 17920183 Review.

8

[German guidelines for the assessment of BPH. What's new in 2007?].

Oelke M, Michel MC, Höfner K. Oelke M, et al. Urologe A. 2008 Feb;47(2):149-54. doi: 10.1007/s00120-007-1609-x. Urologe A. 2008. PMID: 18210073 German.

9

Drug-induced urinary incontinence.

Tsakiris P, Oelke M, Michel MC. Tsakiris P, et al. Among authors: oelke m. Drugs Aging. 2008;25(7):541-9. doi: 10.2165/00002512-200825070-00001. Drugs Aging. 2008. PMID: 18582143 Review.

10

Tolerability of amine uptake inhibitors in urologic diseases.

Michel MC, Ruhe HG, de Groot AA, Castro R, Oelke M. Michel MC, et al. Among authors: oelke m. Curr Drug Saf. 2006 Jan;1(1):73-85. doi: 10.2174/157488606775252601. Curr Drug Saf. 2006. PMID: 18690917 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters